How Common Is Multiple Sclerosis in Different Countries and Why?

This video shows prevalence data for multiple sclerosis in different countries Selected Sources: Prevalence of multiple sclerosis in Cuenca, Ecuador: https://www.ncbi.nlm.nih.gov/pmc/arti.... Why are MS rates so high in Syracuse? https://www.upstate.edu/whatsup/2020/.... Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran: https://www.ncbi.nlm.nih.gov/pmc/arti.... A global perspective on the burden of multiple sclerosis: https://www.thelancet.com/pdfs/journa... Multiple sclerosis epidemiology in Latin America: An updated survey: https://journals.sagepub.com/doi/full... Clinical epidemiology of multiple sclerosis in Moscow. Descriptive epidemiology in population of one region of Moscow]: https://pubmed.ncbi.nlm.nih.gov/24300... Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study: https://journals.sagepub.com/doi/abs/... Multiple sclerosis epidemiology in Asia and Oceania; A systematic review and meta-analysis: https://pubmed.ncbi.nlm.nih.gov/34247... Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil: https://bmcneurol.biomedcentral.com/a... Epidemiologic trends of multiple sclerosis in Puerto Rico (2013-2020): https://pubmed.ncbi.nlm.nih.gov/36544... Multiple sclerosis prevalence in Salta City, Argentina: https://www.sciencedirect.com/science... Prevalence in India: https://www.sciencedirect.com/science... High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition: https://pubmed.ncbi.nlm.nih.gov/9647300/ Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation: https://pubmed.ncbi.nlm.nih.gov/11490... novel method for calculating prevalence of multiple sclerosis in Australia: https://journals.sagepub.com/doi/10.1... Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil: https://bmcneurol.biomedcentral.com/a... EBV seroprevalence in Thailand (where the risk of MS is 130,000:1) is ~100%: https://www.researchgate.net/figure/T... B cell activation, proliferation, and transformation by Epstein-Barr virus infection: https://www.mykst.org/skin/default/2n... Comment or ask questions below! I would be happy to answer! Subscribe on YouTube for more videos every Wednesday! Make video requests in the comments section! Check out my book “Resilience in the Face of Multiple Sclerosis” FREE on Amazon: https://amazon.com/dp/B07WP7H5LK It's about 5 people with MS who live incredible lives, the science and psychology of resilience, mindfulness, and ho’oponopono. Paperback priced to generate $0 royalty. Dr. Brandon Beaber is a board-certified neurologist with subspecialty training in multiple sclerosis and other immunological diseases of the nervous system. He is a partner in the Southern California Permanente Medical Group and practices in Downey, California (South Los Angeles). He has several publications on MS epidemiology and has participated in clinical trials for MS therapeutics. You can follow him on twitter @Brandon_Beaber where he regularly posts about MS news and research. Follow me on twitter:   / brandon_beaber   Music: INNER GRACE - Copyright 2018 Wilton Vought Source: Really Really Free Music Link:    • Video   T he video material by Dr. Brandon Beaber is general educational material on health conditions and is not intended to be used by viewers to diagnose or treat any individual's medical condition. Specifically, this material is not a substitute for individualized diagnostic and treatment advice by a qualified medical/health practitioner, licensed in your jurisdiction, who has access to the relevant information available from diagnostic testing, medical interviews, and a physical examination. To the extent that Dr. Beaber endorses any lifestyle change, behavioral intervention, or supplements, the viewer should consult with a qualified healthcare professional to determine the safety and efficacy of the intervention in light of their individualized information.